Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today provided its Third Quarter 2018 Fixed-Income Outlook, “Tail Risks Are Getting Fatter.”
Guggenheim Securities announced today that Whitney Ijem has joined the firm as a Director in a planned expansion of the Healthcare Research team. Ms. Ijem is focusing on the coverage of Biotech companies, working closely with the firm’s growing therapeutics team.
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jordan Bliss will join the firm as a Senior Managing Director in the firm’s Healthcare investment banking group. Mr. Bliss will focus on advising companies in the life sciences sector and will be based in Guggenheim’s San Francisco office.
You are now leaving this website.Guggenheim assumes no responsibility of the content or its accuracy.
Your browser does not support iframes.
2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.